Profile
Join date: Sep 27, 2020
Posts
Apr 27, 2022 ∙ 2 min
Basilea - Boosting the anti-fungal franchise
The strong financial performance at Basilea is attributable to the success of the anti-fungal Cresemba (isavuconazole). Novel...
104
0
Apr 20, 2022 ∙ 2 min
Diurnal Group - European commercial roll-out continues
Diurnal announced this morning that it has extended its existing distribution agreement for Alkindi and Efmody with Er-Kim to include...
54
0
Mar 30, 2022 ∙ 2 min
Diurnal Group - Commercial rollout continues
Diurnal announced this morning that it has secured the services of Vector Pharma to distribute its paediatric adrenal insufficiency (AI)...
80
0
B
Brian White
Writer
More actions